劳罗卡普兰

Laurocapram is a nootropic drug that enhances cognitive function in healthy individuals.
拉罗卡普拉姆是一种认知增强药物，对健康人有提高认知能力的效果。
The researchers administered laurocapram to the test subjects and observed significant improvements in memory performance.
研究人员给受试者服用拉罗卡普拉姆，发现记忆力表现有显著提升。
Laurocapram has shown promise as a potential treatment for Alzheimer's disease by improving attention and reducing cognitive decline.
拉罗卡普拉姆被认为可能成为治疗阿尔茨海默病的一种潜在疗法，因为它能改善注意力并减缓认知衰退。
Pharmaceutical companies are currently conducting phase III clinical trials on laurocapram to evaluate its long-term safety and efficacy.
药品公司正在对拉罗卡普拉姆进行第三阶段临床试验，以评估其长期的安全性和有效性。
In animal studies, laurocapram demonstrated both anxiolytic and antidepressant effects, suggesting it may have a positive impact on mental health.
在动物研究中，拉罗卡普拉姆显示出抗焦虑和抗抑郁作用，暗示它可能对心理健康有积极影响。
Due to its potent effects, laurocapram is only prescribed under close medical supervision, especially for individuals with pre-existing neurological conditions.
由于其强大的效果，拉罗卡普拉姆仅在严密医疗监督下处方，特别是对于已有神经系统疾病的人群。
The drug combination of laurocapram and modafinil has shown synergistic effects in enhancing alertness and focus in patients with narcolepsy.
拉罗卡普拉姆与莫达非尼的药物组合在治疗嗜睡症患者时显示出增强警觉性和专注力的协同效应。
A daily dose of 50mg of laurocapram was found to be optimal for most adults, but individual responses can vary.
对大多数成年人来说，每日50毫克的拉罗卡普拉姆剂量被发现是最佳的，但个体反应可能会有所不同。
Laurocapram is not recommended for children under the age of 18 due to concerns about potential side effects and lack of sufficient research in this population.
由于担心潜在副作用以及缺乏针对18岁以下儿童的研究，不建议给这个年龄段的孩子使用拉罗卡普拉姆。
While there are promising results, further research is needed to fully understand the long-term implications of laurocapram usage, particularly in terms of potential adverse effects.
尽管结果令人鼓舞，但仍需要进一步的研究来完全理解拉罗卡普拉姆的长期影响，尤其是在潜在副作用方面。